Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: the Cancer-DACUS Study.

@article{Napolitano2014OptimalDO,
  title={Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: the Cancer-DACUS Study.},
  author={Mariasanta Napolitano and Giorgia Saccullo and Alessandra Malato and Delia Sprini and Walter Ageno and Davide Imberti and Doris Mascheroni and Eugenio Bucherini and Pina Gallucci and Andrea D’Alessio and Tullia Prantera and Pietro Spadaro and Stefano Rotondo and Pierpaolo di Micco and Vincenzo Oriana and Oreste Urbano and Francesco Peter Recchia and Angelo Ghirarduzzi and Lucio Lo Coco and Salvatrice Mancuso and Alessandra Casuccio and Giovam Battista Rini and Sergio Siragusa},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2014},
  volume={32 32},
  pages={
          3607-12
        }
}
PURPOSE We evaluated the role of residual vein thrombosis (RVT) to assess the optimal duration of anticoagulants in patients with cancer who have deep vein thrombosis (DVT) of the lower limbs. PATIENTS AND METHODS Patients with active cancer and a first episode of DVT treated with low molecular weight heparin (LMWH) for 6 months were eligible. Patients were managed according to RVT findings: those with RVT were randomly assigned to continue LMWH for an additional 6 months (group A1) or to… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 23 CITATIONS

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.

VIEW 5 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Thrombosis and Hemostasis in Cancer

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).

VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

Physicians Evidence - Based Clinical Practice Guidelines

  • RD Hull, GF Pineo, RF Brant
  • 2012